Researchers have uncovered an unexpected weakness in pancreatic cancer involving damaged mitochondria and a powerful inflammatory signal. Researchers at The Wistar Institute and ChristianaCare’s Helen F. Graham Cancer Center & Research Institute have identified a weakness in pancreatic cancer that may open the door to new treatments. Their study, published in the Proceedings of the […]